Patients will be enrolled over a period of 24 months, and followed for up to 36 months to assess for study outcomes.
This observational matched prospective study aims to assess the effectiveness and adherence for inclisiran in combination with Lipid lowering therapies or Lipid lowering treatments (LLT) compared to other LLTs under conditions of routine clinical practice.